WG
MIST icon

Winton Group’s Milestone Pharmaceuticals MIST Stock Holding History

Winton Group’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2K Buy
+14,300
New +$22.9K ﹤0.01% 1136

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Winton Group's MIST Position: Q2 2026 in Review

Winton Group opened a new position in Milestone Pharmaceuticals (MIST) in Q2 2026: 14,300 shares worth $19.2K. The stake represents ﹤0.01% of the portfolio and ranks #1136 among its holdings.

78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Winton Group held 14,300 shares of Milestone Pharmaceuticals worth $19.2K as of Q2 2026.
  • Milestone Pharmaceuticals was a new Winton Group position in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1136 holding.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.